Acute response to 3.0 ppm formaldehyde in exercising healthy nonsmokers and asthmatics

D. J. Green, L. R. Sauder, T. J. Kulle, Rebecca Bascom

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Formaldehyde is an ubiquitous industrial and indoor air pollutant to which millions are daily exposed. Because of the paucity of scientific data concerning the inhalation toxicity of this compound in humans, we determined the symptoms and alterations in pulmonary function resulting from inhalation for 1 h of 3 parts per million formaldehyde in a controlled environmental chamber. The protocol consisted of randomized exposure of each subject to clean air or 3.0 ppm HCHO on 2 separate days. Twenty-two healthy normal subjects engaged in intermittent heavy exercise (V̇(E) = 65 L/min) and 16 asthmatic subjects performed intermittent moderate exercise (V̇(E) = 37 L/min). Symptoms and pulmonary function were assessed during the time course of exposure; nonspecific airway reactivity was assessed after exposure. Both groups exhibited similar, significant (p < 0.01) increases in perceived odor, nose/throat irritation, and eye irritation throughout the exposure. The normal group had the following statistically significant (p < 0.02)) lower pulmomary functions after 55 min of exposure to formaldehyde as compared to clean air: 3.8% in FEV1, 2.6% in FVC, and 2.8% in FEV3. The asthmatic group showed no statistically significant decrements in pulmonary function. Five of 38 subjects studied had decrements in FEV1 greater than 10%. In conclusion, acute exposure to 3 ppm HCHO produced: (1) consistent irritant symptoms in both normal and asthmatic subjects, (2) small decreases in pulmonary function in normal subjects engaging in heavy exercise, and (3) clinically significant responses (defined as decrements in FEV1 greater than 10%) in 13% of the study population. These data suggest that some persons will demonstrate an increased responsiveness to HCHO. The basis of this altered responsiveness is unknown at this time.

Original languageEnglish (US)
Pages (from-to)1261-1266
Number of pages6
JournalAmerican Review of Respiratory Disease
Volume135
Issue number6
DOIs
StatePublished - Jan 1 1987

Fingerprint

Formaldehyde
Lung
Exercise
Inhalation
Air
Air Pollutants
Irritants
Pharynx
Nose
Healthy Volunteers
Population

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

@article{13564bba0103407980ddae837d8b2eed,
title = "Acute response to 3.0 ppm formaldehyde in exercising healthy nonsmokers and asthmatics",
abstract = "Formaldehyde is an ubiquitous industrial and indoor air pollutant to which millions are daily exposed. Because of the paucity of scientific data concerning the inhalation toxicity of this compound in humans, we determined the symptoms and alterations in pulmonary function resulting from inhalation for 1 h of 3 parts per million formaldehyde in a controlled environmental chamber. The protocol consisted of randomized exposure of each subject to clean air or 3.0 ppm HCHO on 2 separate days. Twenty-two healthy normal subjects engaged in intermittent heavy exercise (V̇(E) = 65 L/min) and 16 asthmatic subjects performed intermittent moderate exercise (V̇(E) = 37 L/min). Symptoms and pulmonary function were assessed during the time course of exposure; nonspecific airway reactivity was assessed after exposure. Both groups exhibited similar, significant (p < 0.01) increases in perceived odor, nose/throat irritation, and eye irritation throughout the exposure. The normal group had the following statistically significant (p < 0.02)) lower pulmomary functions after 55 min of exposure to formaldehyde as compared to clean air: 3.8{\%} in FEV1, 2.6{\%} in FVC, and 2.8{\%} in FEV3. The asthmatic group showed no statistically significant decrements in pulmonary function. Five of 38 subjects studied had decrements in FEV1 greater than 10{\%}. In conclusion, acute exposure to 3 ppm HCHO produced: (1) consistent irritant symptoms in both normal and asthmatic subjects, (2) small decreases in pulmonary function in normal subjects engaging in heavy exercise, and (3) clinically significant responses (defined as decrements in FEV1 greater than 10{\%}) in 13{\%} of the study population. These data suggest that some persons will demonstrate an increased responsiveness to HCHO. The basis of this altered responsiveness is unknown at this time.",
author = "Green, {D. J.} and Sauder, {L. R.} and Kulle, {T. J.} and Rebecca Bascom",
year = "1987",
month = "1",
day = "1",
doi = "10.1164/arrd.1987.135.6.1261",
language = "English (US)",
volume = "135",
pages = "1261--1266",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "6",

}

Acute response to 3.0 ppm formaldehyde in exercising healthy nonsmokers and asthmatics. / Green, D. J.; Sauder, L. R.; Kulle, T. J.; Bascom, Rebecca.

In: American Review of Respiratory Disease, Vol. 135, No. 6, 01.01.1987, p. 1261-1266.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Acute response to 3.0 ppm formaldehyde in exercising healthy nonsmokers and asthmatics

AU - Green, D. J.

AU - Sauder, L. R.

AU - Kulle, T. J.

AU - Bascom, Rebecca

PY - 1987/1/1

Y1 - 1987/1/1

N2 - Formaldehyde is an ubiquitous industrial and indoor air pollutant to which millions are daily exposed. Because of the paucity of scientific data concerning the inhalation toxicity of this compound in humans, we determined the symptoms and alterations in pulmonary function resulting from inhalation for 1 h of 3 parts per million formaldehyde in a controlled environmental chamber. The protocol consisted of randomized exposure of each subject to clean air or 3.0 ppm HCHO on 2 separate days. Twenty-two healthy normal subjects engaged in intermittent heavy exercise (V̇(E) = 65 L/min) and 16 asthmatic subjects performed intermittent moderate exercise (V̇(E) = 37 L/min). Symptoms and pulmonary function were assessed during the time course of exposure; nonspecific airway reactivity was assessed after exposure. Both groups exhibited similar, significant (p < 0.01) increases in perceived odor, nose/throat irritation, and eye irritation throughout the exposure. The normal group had the following statistically significant (p < 0.02)) lower pulmomary functions after 55 min of exposure to formaldehyde as compared to clean air: 3.8% in FEV1, 2.6% in FVC, and 2.8% in FEV3. The asthmatic group showed no statistically significant decrements in pulmonary function. Five of 38 subjects studied had decrements in FEV1 greater than 10%. In conclusion, acute exposure to 3 ppm HCHO produced: (1) consistent irritant symptoms in both normal and asthmatic subjects, (2) small decreases in pulmonary function in normal subjects engaging in heavy exercise, and (3) clinically significant responses (defined as decrements in FEV1 greater than 10%) in 13% of the study population. These data suggest that some persons will demonstrate an increased responsiveness to HCHO. The basis of this altered responsiveness is unknown at this time.

AB - Formaldehyde is an ubiquitous industrial and indoor air pollutant to which millions are daily exposed. Because of the paucity of scientific data concerning the inhalation toxicity of this compound in humans, we determined the symptoms and alterations in pulmonary function resulting from inhalation for 1 h of 3 parts per million formaldehyde in a controlled environmental chamber. The protocol consisted of randomized exposure of each subject to clean air or 3.0 ppm HCHO on 2 separate days. Twenty-two healthy normal subjects engaged in intermittent heavy exercise (V̇(E) = 65 L/min) and 16 asthmatic subjects performed intermittent moderate exercise (V̇(E) = 37 L/min). Symptoms and pulmonary function were assessed during the time course of exposure; nonspecific airway reactivity was assessed after exposure. Both groups exhibited similar, significant (p < 0.01) increases in perceived odor, nose/throat irritation, and eye irritation throughout the exposure. The normal group had the following statistically significant (p < 0.02)) lower pulmomary functions after 55 min of exposure to formaldehyde as compared to clean air: 3.8% in FEV1, 2.6% in FVC, and 2.8% in FEV3. The asthmatic group showed no statistically significant decrements in pulmonary function. Five of 38 subjects studied had decrements in FEV1 greater than 10%. In conclusion, acute exposure to 3 ppm HCHO produced: (1) consistent irritant symptoms in both normal and asthmatic subjects, (2) small decreases in pulmonary function in normal subjects engaging in heavy exercise, and (3) clinically significant responses (defined as decrements in FEV1 greater than 10%) in 13% of the study population. These data suggest that some persons will demonstrate an increased responsiveness to HCHO. The basis of this altered responsiveness is unknown at this time.

UR - http://www.scopus.com/inward/record.url?scp=0023632177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023632177&partnerID=8YFLogxK

U2 - 10.1164/arrd.1987.135.6.1261

DO - 10.1164/arrd.1987.135.6.1261

M3 - Article

C2 - 3592401

AN - SCOPUS:0023632177

VL - 135

SP - 1261

EP - 1266

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 6

ER -